MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet

MONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) —  The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc. (Nasdaq: MGRM) (“Monogram”) to Zimmer Biomet for an upfront payment of $4.04 per share in cash, and a non-tradeable contingent value right (CVR) entitling the holder to receive up to $12.37 per share in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

At least two investors have already expressed extreme disappointment in the sale price on SeekingAlpha.

If you remain a Monogram shareholder and have concerns about the proposed sale, you may contact our firm at the following link to discuss your legal rights at no charge:

https://wohlfruchter.com/cases/monogram-technologies/

Alternatively, you may contact us by phone at 866-833-6245, or via email at [email protected].

Why is there an investigation?
On July 14, 2025, Monogram announced that it had agreed to be sold to Zimmer Biomet for an upfront payment of $4.04 per share in cash, and a non-tradeable CVR entitling the holder to receive up to $12.37 per share in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

At least two investors have expressed disappointment in the sale price on SeekingAlpha with one investor complaining, “Too cheap!,” and another responding that “I am not very happy about it either.”

“We are investigating whether the Monogram Board of Directors acted in the best interests of Monogram shareholders in approving the sale,” explained Joshua Fruchter, a founding partner of Wohl & Fruchter. “This includes whether the price agreed upon is fair to Monogram shareholders, as well as whether all material information regarding the transaction has been fully disclosed.”

About Wohl & Fruchter

Wohl & Fruchter LLP has for over a decade been representing investors in litigation arising from fraud and other corporate misconduct, and recovered hundreds of millions of dollars in damages for investors. Please visit our website, www.wohlfruchter.com, to learn more about our Firm, or contact one of our partners.

Contact:
Wohl & Fruchter LLP
Joshua E. Fruchter
Toll Free 866.833.6245
[email protected]
www.wohlfruchter.com

Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow